Zlatko Rihter

Zlatko Rihter

Director/Miembro de la Junta en SWEDISH ORPHAN BIOVITRUM AB .

Fortuna: 478 921 $ al 31/05/2026

56 años
Health Technology
Consumer Services
Distribution Services

Perfil

Zlatko Rihter is President, Chief Executive Officer & Director at Mölnlycke Health Care, Inc. since 2020.
Mr. Rihter is Chairman at RAL Diagnostics SAS. Mr. Rihter is Director at Mölnlycke AB. Mr. Rihter is Director at Swedish Orphan Biovitrum AB since 2024.
Mr. Rihter is President & Director at Mölnlycke Health Care AB since 2020.
Former roles include President & Chief Executive Officer at CellaVision AB from 2015 to 2020.
Mr. Rihter was Director at Etac AB. Mr. Rihter was Director at Malmö Fotbollsförening.
Mr. Rihter was Executive Vice President-Global Sales & Marketing at Origio A from 2014 to 2015.
Mr. Rihter was President-Global Business Unit Chronic at Gambro Lundia AB from 2012 to 2013.
Mr. Rihter was Vice President-Product Division at ArjoHuntleigh AB from 2006 to 2012.
Education includes graduation from the University of Lund.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/12/2025 10.000 ( 0 % ) 478 921 $ 31/05/2026

Cargos activos de Zlatko Rihter

EmpresasCargoInicio
SWEDISH ORPHAN BIOVITRUM AB Director/Miembro de la Junta 14/05/2024
Presidente 01/01/2020
Presidente -
Director/Miembro de la Junta -
Director Ejecutivo 01/01/2020

Antiguos cargos conocidos de Zlatko Rihter.

EmpresasCargoFin
CELLAVISION AB Director Ejecutivo 28/11/2020
Ventas & Marketing 01/01/2015
Corporate Officer/Principal 01/09/2013
Corporate Officer/Principal 01/06/2012
░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
Ver el detalle de la experiencia de Zlatko Rihter.

Formación de Zlatko Rihter.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

30

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Consumer Services

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology